MONTREAL, Oct. 10 /CNW/ - ConjuChem Biotechnologies Inc. (TSX:CJB)
announced today that it has received, from the U.S. Patent & Trademark Office,
the Order Granting ConjuChem's July 9, 2007 Request for Inter Partes
Reexamination of U.S. Patent No. 6,924,264 ("The Order"). The patent, entitled
"Modified Exendins and Exendin Agonists", was issued in August 2005 and is
assigned to Amylin Pharmaceuticals, Inc.
